Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 2/2007

01-06-2007 | Original Article

Risk factors for central nervous system metastasis in patients with metastatic breast cancer

Authors: Canfeza Sezgin, MD, Erhan Gokmen, Mustafa Esassolak, Necmettin Ozdemir, Erdem Goker

Published in: Medical Oncology | Issue 2/2007

Login to get access
Metadata
Title
Risk factors for central nervous system metastasis in patients with metastatic breast cancer
Authors
Canfeza Sezgin, MD
Erhan Gokmen
Mustafa Esassolak
Necmettin Ozdemir
Erdem Goker
Publication date
01-06-2007
Publisher
Humana Press
Published in
Medical Oncology / Issue 2/2007
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/BF02698034

Other articles of this Issue 2/2007

Medical Oncology 2/2007 Go to the issue

Original Article

DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU

Original Article

Thymic epithelial neoplasia

Original Article

Expression of c-kit proto-oncogene product in breast cancer tissues

Obituary

A tribute to Professor Roberto De Bellis

Review

The management of posttransplant lymphoproliferative disorder

Original Article

Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits